BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021;8:e1080. [PMID: 34452974 DOI: 10.1212/NXI.0000000000001080] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Nabizadeh F, Noori M, Rahmani S, Hosseini H. Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review. J Clin Neurosci 2023;111:57-70. [PMID: 36963124 DOI: 10.1016/j.jocn.2023.03.008] [Reference Citation Analysis]
2 Normandin E, Valizadeh N, Rudmann EA, Uddin R, Dobbins ST, MacInnis BL, Padera RF, Siddle KJ, Lemieux JE, Sabeti PC, Mukerji SS, Solomon IH. Neuropathological features of SARS-CoV-2 delta and omicron variants. J Neuropathol Exp Neurol 2023;82:283-95. [PMID: 36847705 DOI: 10.1093/jnen/nlad015] [Reference Citation Analysis]
3 Weidauer S, Zeitz A, Tafreshi M, Hattingen E, Arendt C. Acute Disseminated Encephalomyelitis and Acute Encephalitis Following Vaccination Against SARS-CoV-2: Two Case Reports and Review of Literature. Fortschr Neurol Psychiatr 2023. [PMID: 36931294 DOI: 10.1055/a-2029-4405] [Reference Citation Analysis]
4 Brock K, Reyes SC, Connor C, Gilson N, Weiss M, Elfituri O, Paydar A. Acute disseminated encephalomyelitis (ADEM)-like illness in a pediatric patient following COVID-19 vaccination. BJR|case reports 2023. [DOI: 10.1259/bjrcr.20220097] [Reference Citation Analysis]
5 Mogensen MA, Filippi CG. Coronavirus Disease: Subacute to Chronic Neuroimaging Findings. Neuroimaging Clin N Am 2023;33:69-82. [PMID: 36404048 DOI: 10.1016/j.nic.2022.07.004] [Reference Citation Analysis]
6 Alqarni AA, Aljafari DA, Alzahrani FA, Alharthi AA, Alhubayshi MS. Acute Disseminated Encephalomyelitis Post COVID-19 Pneumonia. Cureus 2023;15:e34615. [PMID: 36891024 DOI: 10.7759/cureus.34615] [Reference Citation Analysis]
7 Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: A comprehensive review. Psychiatry Clin Neurosci 2023;77:84-93. [PMID: 36385449 DOI: 10.1111/pcn.13508] [Reference Citation Analysis]
8 Malik P, Shroff M. Infection and inflammation: radiological insights into patterns of pediatric immune-mediated CNS injury. Neuroradiology 2023;65:425-39. [PMID: 36534135 DOI: 10.1007/s00234-022-03100-x] [Reference Citation Analysis]
9 Assi F, Abdallah R, Mecheik A, Rahhal HH, Wazne J. Acute Disseminated Encephalomyelitis Following COVID-19 Infection. Cureus 2023;15:e33365. [PMID: 36751218 DOI: 10.7759/cureus.33365] [Reference Citation Analysis]
10 Mohseni Afshar Z, Sharma A, Babazadeh A, Alizadeh-Khatir A, Sio TT, Taghizadeh Moghadam MA, Tavakolli Pirzaman A, Mojadad A, Hosseinzadeh R, Barary M, Ebrahimpour S. A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg 2023;123:9-44. [PMID: 36385246 DOI: 10.1007/s13760-022-02137-2] [Reference Citation Analysis]
11 Fessel J. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid. Discov Ment Health 2023;3:1. [PMID: 36618714 DOI: 10.1007/s44192-022-00027-w] [Reference Citation Analysis]
12 Wu C, Zhang W, Jiao Y, Dong M, Zhou H, Lv Y, Yang J. Two-year follow-up of a young male with possible acute hemorrhagic leukoencephalitis: A case report. Medicine (Baltimore) 2022;101:e32073. [PMID: 36482561 DOI: 10.1097/MD.0000000000032073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Krett JD, Fritzler MJ, Alikhani K, Burton JM. A Quality Assessment of Aquaporin-4 & Myelin Oligodendrocyte Glycoprotein Antibody Testing. Can J Neurol Sci 2022;:1-27. [PMID: 36398407 DOI: 10.1017/cjn.2022.324] [Reference Citation Analysis]
14 Alromaihi M. Acute Hemorrhagic Leukoencephalitis (AHLE): A Comprehensive Review on Causes, Symptoms, Link with COVID-19, Diagnosis, and Treatment. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/6008375] [Reference Citation Analysis]
15 Alexander Muacevic, John R Adler. Acute Disseminated Encephalomyelitis Following Thoracic Endovascular Aortic Repair. Cureus;14:e30562. [PMID: 36415419 DOI: 10.7759/cureus.30562] [Reference Citation Analysis]
16 Furtado C, Jadun C, Srivast S, Nayak S, Hashim Z. Acute Disseminated Encephalomyelitis following Thoracic Endovascular Aortic Repair: An unusual presentation.. [DOI: 10.21203/rs.3.rs-2082527/v1] [Reference Citation Analysis]
17 Fessel J. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid. Qeios 2022. [DOI: 10.32388/cf8mip] [Reference Citation Analysis]
18 Petersson I, Hansen BM, Svenningsson A, Lundstrom A. Cerebral microvascular injuries in severe COVID-19 infection: progression of white matter hyperintensities post-infection. BMJ Case Rep 2022;15:e249156. [DOI: 10.1136/bcr-2022-249156] [Reference Citation Analysis]
19 Tondo G, Virgilio E, Naldi A, Bianchi A, Comi C. Safety of COVID-19 Vaccines: Spotlight on Neurological Complications. Life 2022;12:1338. [DOI: 10.3390/life12091338] [Reference Citation Analysis]
20 Kocabıyık F, Koral K, Pruthi S. Nonvascular Nervous System Complications in Pediatric Patients with COVID-19 Infection. Journal of Pediatric Neurology 2022. [DOI: 10.1055/s-0042-1751264] [Reference Citation Analysis]
21 Aubart M, Roux CJ, Durrleman C, Gins C, Hully M, Kossorotoff M, Gitiaux C, Levy R, Moulin F, Debray A, Belhadjer Z, Georget E, Kom T, Blanc P, Wehbi S, Mazeghrane M, Tencer J, Gajdos V, Rouget S, De Pontual L, Basmaci R, Yacouben K, Angoulvant F, Leruez-Ville M, Sterlin D, Rozenberg F, Robert MP, Zhang SY, Boddaert N, Desguerre I. Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. J Pediatr 2022;247:22-28.e2. [PMID: 35577119 DOI: 10.1016/j.jpeds.2022.05.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Battaglini D, Premraj L, Griffee M, Huth S, Fanning J, Whitman G, Bastos Porto D, Arora R, Durham L, Gnall E, Amato M, Williams V, Noel A, De Franca SA, Samoukovic G, Pujo B, Kent D, Marwali E, Al-fares A, Stecher S, Panigada M, Giani M, Foti G, Pelosi P, Pesenti A, White NM, Li Bassi G, Suen J, Fraser JF, Robba C, Cho S. Neurological Manifestations of SARS-CoV-2 Infection: Protocol for a Sub-analysis of the COVID-19 Critical Care Consortium Observational Study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.930217] [Reference Citation Analysis]
23 Graham EL, Koralnik IJ, Liotta EM. Therapeutic Approaches to the Neurologic Manifestations of COVID-19. Neurotherapeutics 2022. [PMID: 35861926 DOI: 10.1007/s13311-022-01267-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Vlasenko AI, Portik OA, Bisaga GN, Topuzova MP, Malko VA, Isabekova PS, Skripchenko NV, Alekseeva TM. Relationship between SARS-COV-2 And autoimmune neurological diseases. jour 2022;14:65-72. [DOI: 10.22625/2072-6732-2022-14-2-65-72] [Reference Citation Analysis]
25 Balik AÖ, Gurdal Kosem E. Acute Disseminated Encephalomyelitis with Prefrontal Cortex Involvement in a 9-Year-Old Child after COVID-19 Infection: A Case Report. Journal of Pediatric Neurology 2022. [DOI: 10.1055/s-0042-1747964] [Reference Citation Analysis]
26 Li K, Li M, Wen L, Wang Q, Ding X, Wang J. Clinical Presentation and Outcomes of Acute Disseminated Encephalomyelitis in Adults Worldwide: Systematic Review and Meta-Analysis. Front Immunol 2022;13:870867. [PMID: 35757742 DOI: 10.3389/fimmu.2022.870867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Alam AM, Easton A, Nicholson TR, Irani SR, Davies NW, Solomon T, Michael BD. Encephalitis: diagnosis, management and recent advances in the field of encephalitides. Postgrad Med J 2022:postgradmedj-2022-141812. [PMID: 35738892 DOI: 10.1136/postgradmedj-2022-141812] [Reference Citation Analysis]
28 Johnsson M, Asztely F, Hejnebo S, Axelsson M, Malmeström C, Olausson T, Lycke J. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder. Ann Clin Transl Neurol 2022. [PMID: 35713508 DOI: 10.1002/acn3.51609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Hutto SK, Venna N. Response to Letter to the Editor: Spinomedullary Weston Hurst Syndrome After COVID-19 and Influenza Co-Infection. The Neurohospitalist. [DOI: 10.1177/19418744221109218] [Reference Citation Analysis]
30 Gao JJ, Tseng HP, Lin CL, Hsu RF, Lee MH, Liu CH. Acute encephalitis after COVID-19 vaccination: A case report and literature review. Hum Vaccin Immunother 2022;:2082206. [PMID: 35700455 DOI: 10.1080/21645515.2022.2082206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
31 Hollen C, Bernard J. Multiple Sclerosis Management During the COVID-19 Pandemic. Curr Neurol Neurosci Rep 2022. [PMID: 35687314 DOI: 10.1007/s11910-022-01211-9] [Reference Citation Analysis]
32 Hardy TA, Guo Y, Flanagan EP, Lucchinetti CF, Tobin WO. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions. Mult Scler 2022;:13524585221094241. [PMID: 35581949 DOI: 10.1177/13524585221094241] [Reference Citation Analysis]
33 Ghosh R, Chatterjee S, Roy D, Finsterer J, Lahiri D, Dubey S, Benito‐león J. Weston Hurst hemorrhagic leukoencephalitis: A novel association with mixed connective tissue disease: uncloaking the “unholy” etiology underneath. Clinical & Exp Neuroim 2022. [DOI: 10.1111/cen3.12701] [Reference Citation Analysis]
34 Magalhães JE, Sampaio-Rocha-Filho PA. Pregnancy and neurologic complications of COVID-19: A scoping review. Acta Neurol Scand 2022. [PMID: 35388457 DOI: 10.1111/ane.13621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Kim HK. Epilepsy and COVID-19: Recent Findings and Considerations. Epilia: Epilepsy Commun 2022;4:13-19. [DOI: 10.35615/epilia.2022.00312] [Reference Citation Analysis]
36 Matsumoto Y, Ohyama A, Kubota T, Ikeda K, Kaneko K, Takai Y, Warita H, Takahashi T, Misu T, Aoki M. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review. Front Neurol 2022;13:845755. [PMID: 35299613 DOI: 10.3389/fneur.2022.845755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
37 Benevides ML, Elias S, Fagundes DA, Martins RF, Dutra MM, Rodrigues de Oliveira Thais ME, Rodrigues GM, Nunes JC, Martins GL. Acute Hemorrhagic Leukoencephalopathy Triggered by COVID-19 Infection. The Neurohospitalist. [DOI: 10.1177/19418744221077735] [Reference Citation Analysis]
38 Ancau M, Liesche-starnecker F, Niederschweiberer J, Krieg SM, Zimmer C, Lingg C, Kumpfmüller D, Ikenberg B, Ploner M, Hemmer B, Wunderlich S, Mühlau M, Knier B. Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination. Front Neurol 2022;12:820049. [DOI: 10.3389/fneur.2021.820049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
39 Gelibter S, Bellavia G, Arbasino C, Arnò N, Glorioso M, Mazza S, Murelli R, Sciarretta M, Dallocchio C. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19. J Neurol 2022. [PMID: 34978621 DOI: 10.1007/s00415-021-10947-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Gerhard A, Prüß H, Franke C. [Manifestations of the central nervous system after COVID-19]. Nervenarzt 2022;93:769-78. [PMID: 35552466 DOI: 10.1007/s00115-022-01294-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Chakraborty AP, Pandit A, Dutta A, Das S, Ganguly G, Dubey S. Transcortical sensory aphasia heralding SARS-Cov-2-induced autoimmune encephalitis with gyral restricted diffusion hyperintensities: a novel case report. Egypt J Neurol Psychiatr Neurosurg 2022;58:167. [PMID: 36597448 DOI: 10.1186/s41983-022-00593-4] [Reference Citation Analysis]
42 Walton D, Acampora R, Wood GK, Premi E, Ilie IA, Lanfranchi F, Michael BD. Neurological Complications of COVID-19. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_18] [Reference Citation Analysis]
43 Rizvi I, Garg RK, Gupta P, Malhotra HS, Kumar N, Uniyal R, Pandey S. Acute hemorrhagic leukoencephalitis after administration of the first dose of ChAdOx1 nCoV-19 SARS-CoV-2 (COVISHIELD™) vaccine. Neuroimmunology Reports 2022;2:100089. [DOI: 10.1016/j.nerep.2022.100089] [Reference Citation Analysis]
44 Moccia M. Demyelinating disorders following COVID-19 vaccination. Mult Scler 2021;:13524585211046903. [PMID: 34590873 DOI: 10.1177/13524585211046903] [Reference Citation Analysis]
45 Li X, Martinez-hernandez E, Roel Herranz E, Delmestri A, Duarte-salles T, Strauss V, Burn E, Prieto-alhambra D. “Association between COVID-19 vaccination, infection, and risk of Guillain-Barre syndrome, Bell’s palsy, encephalomyelitis and transverse myelitis: a population-based cohort and self-controlled case series analysis”.. [DOI: 10.1101/2021.09.08.21263276] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]